Page last updated: 2024-08-26

tretazicar and flucytosine

tretazicar has been researched along with flucytosine in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chen, MJ; Chung-Faye, GA; Kerr, DJ; Searle, PF; Young, LS	1
Brunicardi, FC; Fisher, WE; Yazawa, K	1
Dachs, GU; Hunt, MA; Patterson, AV; Singleton, DC; Syddall, S	1
Chang, D; Chang, HF; Chen, BM; Chen, SH; Chen, TC; Collins, S; Kasahara, N; Lin, SC; Lu, YC; Sun, JM; Tai, CK; Wang, HE; Wang, W; Wu, SF	1

Reviews

3 review(s) available for tretazicar and flucytosine

Article	Year
Gene therapy for colorectal cancer: therapeutic potential. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2001, Volume: 15, Issue:6 Topics: Adenoviridae; Antigen Presentation; Aziridines; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Flucytosine; Ganciclovir; Genes, p53; Genetic Therapy; Humans; T-Lymphocytes, Cytotoxic	2001
Current progress in suicide gene therapy for cancer. World journal of surgery, 2002, Volume: 26, Issue:7 Topics: Animals; Antiviral Agents; Arabinonucleosides; Aziridines; Clinical Trials as Topic; Cytosine Deaminase; Escherichia coli; Flucytosine; Ganciclovir; Genetic Therapy; Genetic Vectors; Herpesvirus 3, Human; Humans; Neoplasms; Nitroreductases; Nucleoside Deaminases; Pentosyltransferases; Prodrugs; Purine Nucleosides; Simplexvirus; Thymidine Kinase; Xanthines	2002
Bystander or no bystander for gene directed enzyme prodrug therapy. Molecules (Basel, Switzerland), 2009, Nov-10, Volume: 14, Issue:11 Topics: Animals; Aziridines; Cytosine Deaminase; Flucytosine; Ganciclovir; Genetic Therapy; Humans; Nitroreductases; Prodrugs; Thymidine Kinase	2009

Other Studies

2 other study(ies) available for tretazicar and flucytosine

Article	Year
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model. International journal of molecular sciences, 2020, Feb-20, Volume: 21, Issue:4 Topics: Animals; Aziridines; Brain Neoplasms; Cell Line, Tumor; Cytosine Deaminase; Escherichia coli Proteins; Flucytosine; Genetic Therapy; Genetic Vectors; Glioma; Leukemia Virus, Gibbon Ape; Neoplasms, Experimental; Nitroreductases; Prodrugs; Rats, Inbred F344; Saccharomyces cerevisiae Proteins	2020

Article

Year

Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008

Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model.

International journal of molecular sciences, 2020, Feb-20, Volume: 21, Issue:4

Topics: Animals; Aziridines; Brain Neoplasms; Cell Line, Tumor; Cytosine Deaminase; Escherichia coli Proteins; Flucytosine; Genetic Therapy; Genetic Vectors; Glioma; Leukemia Virus, Gibbon Ape; Neoplasms, Experimental; Nitroreductases; Prodrugs; Rats, Inbred F344; Saccharomyces cerevisiae Proteins

2020